Early Access — free while we kick the tires
EdgarHawk

Sachdev Amit

EVP Chief Patient & Ext Af Off

Officer
1 filing analyzed · 1 company · Latest 2026-02-23

Companies

Company Buys Sells Direction
VERTEX PHARMACEUTICALS INC / MA VRTX 0 10 Net selling

Activity

February 2026
medium
Sell
58,613 shares
$27,479,583
Significance 5/10

EVP Sachdev sells 58.6K shares (49.9% of holdings) for $27.5M at VRTX on 2026-02-19

Sachdev Amit, EVP Chief Patient & External Affairs Officer, executed 8 separate sales totaling 58,613 shares for $27,479,583.09 on 2026-02-19, reducing his holdings from 117,547 shares to 58,934 shares—a 49.9% reduction in position size. The sales occurred across a narrow price band ($463.91 to $471.43) with a blended average of $468.83, and at current price of $481.01 the shares are trading above the transaction prices, suggesting the insider sold ahead of modest subsequent appreciation. His same-ticker track record at VRTX shows 5 prior sells with a timing pattern of 0 of 5 well-timed at the 90-day mark (prior sales saw subsequent gains averaging +5.3% over 90 days), whereas his cross-ticker track record across all holdings shows 5 prior sells with a 90-day well-timed rate of 0.00%. This large-scale reduction in a high-conviction position (nearly half of holdings) warrants monitoring of any material business developments that may have prompted the sale.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access